Key result
The InSeal vascular closure device is safe and effective for achieving hemostasis following transcatheter aortic valve replacement.
Why the study?
Is the InSeal vascular closure device safe and effective for achieving hemostasis in patients undergoing transcatheter aortic valve replacement?
Is the InSeal vascular closure device safe and effective for achieving hemostasis in patients undergoing transcatheter aortic valve replacement?
The novel InSeal vascular closure device appears to be a safe and effective option for achieving hemostasis following large-bore access procedures such as TAVR.
There is an exponential growth in the numbers of procedures requiring large-bore access. InSeal vascular closure device (VCD) is a novel device that seals the puncture with a biodegradable membrane, which is supported by a self-expanding nitinol frame. The current study suggests that the InSeal VCD is safe and effective in achieving hemostasis after transcatheter aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Çilingiroğlu et al. (2020) studied this question. The InSeal vascular closure device is safe and effective for achieving hemostasis following transcatheter aortic valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: